中国泰达国际心血管病医院和中国运载火箭技术研究院研制的HeartCon人工心脏，利用航天技术挽救了190名严重心力衰竭患者。 China's TEDA International Cardiovascular Hospital & China Academy of Launch Vehicle Technology developed the HeartCon artificial heart, saving 190 severe heart failure patients using aerospace technology.

中国泰达国际心血管医院和中国运载火箭技术研究院研制的HeartCon人工心脏，挽救了190名严重心力衰竭患者。 China's TEDA International Cardiovascular Hospital & China Academy of Launch Vehicle Technology developed the HeartCon artificial heart, saving 190 severe heart failure patients. 在航空航天技术的推动下,这种比进口产品更廉价的替代产品可以发挥火箭的观测机械作用,在人体器官移植有限的情况下延长寿命。 Powered by aerospace technology, this cheaper alternative to imported products functions as a rocket's servomechanism & extends lives where human organ transplants are limited. 自2022年获得市场批准以来, " 心电图二 " 正在接受测试。 Since gaining market approval in 2022, HeartCon II is being tested.